# Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

> **NCT00993122** · PHASE4 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 100 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** ribavirin pre-treatment

## Key facts

- **NCT ID:** NCT00993122
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-04
- **Final completion:** 2012-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993122, "Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00993122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*